February 15, 2017 / 12:42 PM / in 9 months

BRIEF-Insys says Cannabidiol Oral Solution for compassionate use studies being provided at no cost

Feb 15 (Reuters) - Insys Therapeutics Inc

* Insys therapeutics - providing for use of cannabidiol oral solution for compassionate use studies in patients completing long-term safety study

* Insys therapeutics says use of cannabidiol oral solution at doses up to 40 mg/kg/day for compassionate use studies in refractory pediatric epilepsy patients

* Insys therapeutics inc - cannabidiol oral solution for compassionate use studies is being provided at no cost to patients or investigators Source text for Eikon: Further company coverage:

Our Standards:The Thomson Reuters Trust Principles.
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below